Sana Capital hosted The Allocators' Evening at the Oxford and Cambridge Club during London VC Week - bringing together LPs, family offices and fund managers who push the frontier and discuss the future of deep tech investing in the UK. Nothing beats a gathering of like-minded people who want to use their talents, resources and network to effect lasting change. Sana Capital was honoured to host The Allocators' Evening as part of London Venture Capital Week - an exclusive conve

🌟 UPDATE - Applications PAUSED Thank you so much to everyone who has applied for the Founder's Associate Programme. We have been overwhelmed by both the volume and the quality of applications received. We have committed to getting back to candidates within 72 hours, so we have decided to pause accepting new applications while we work our way through those already received. If we reopen, we will update this page and post again on LinkedIn. Thank you for your interest in Sana

Hanadi Jabado spoke at the European Parliament during the launch of the EU’s Gender Gap in Investments study — calling for real power for women in deep tech finance and transparency in fund management.

Hanadi Jabado joins EU leaders in Brussels to address the Gender Investment Gap. Discover how Sana Capital is backing women fund managers and founders to build a more inclusive, high-performing innovation economy.

Four female venture capital leaders reflect on International Women’s Day and the importance of diversity in life sciences and venture capital. Hear from Hanadi Jabado, Jia-Yi Har, Diana Saraceni, and Susannah McClintock on how empowering women in STEM drives innovation and impact.

Sana Capital’s Hanadi Jabado joins The Other Side of the Table to discuss TechBio and Life Science investing, the power of trust in founder–investor relationships, and why the market may not recover until 2025.

Deep-tech investor Hanadi Jabado, Co-Founder of Sana Capital and creator of Accelerate Cambridge, shares insights on TechBio, commercialization from academia, women in venture capital, and how inclusive investment will shape innovation in 2025.

Sana Capital’s Hanadi Jabado reveals how TechBio uses AI, data and decentralised trials to accelerate drug development and cut regulatory red tape — and why investors need native fluency in both tech and biotech to lead this shift.

Sana Capital’s Hanadi Jabado explains how TechBio, AI and data will disrupt healthcare — and why global data sharing and data donation are now essential to unlock prevention, personalised medicine, and lower system costs.